GILT Modulates CD4 + T-Cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1

Matthew P. Rausch, Karen Taraszka Hastings

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Gamma-IFN-inducible lysosomal thiol reductase (GILT) facilitates major histocompatibility complex class II-restricted processing through endocytic reduction of protein disulfide bonds and is necessary for efficient class II-restricted processing of melanocyte differentiation antigen, tyrosinase-related protein 1 (TRP1). Using class II-restricted, TRP1-specific T-cell receptor transgenic mice, we identify a role, to our knowledge, previously unreported, for GILT in the maintenance of tolerance to TRP1. TRP1-specific thymocytes are centrally deleted in the presence of GILT and TRP1. In contrast, CD4 + single-positive thymocytes and peripheral T cells develop in the absence of GILT or TRP1, demonstrating that GILT is required for negative selection of TRP1-specific thymocytes. Although TRP1-specific T cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do not induce vilitigo. TRP1-specific T cells that develop in the absence of GILT have diminished IL-2 and IFN-γ production. Furthermore, GILT-deficient mice have a 4-fold increase in the percentage of TRP1-specific regulatory T (Treg) cells compared with TRP1-deficient mice, and depletion of Treg cells partially restores the ability of GILT-deficient TRP1-specific CD4 + T cells to induce vitiligo. Thus, GILT has a critical role in regulating CD4 + T-cell tolerance to an endogenous skin-restricted antigen relevant to controlling autoimmunity and generating effective immunotherapy for melanoma.

Original languageEnglish (US)
Pages (from-to)154-162
Number of pages9
JournalJournal of Investigative Dermatology
Volume132
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

T-cells
Melanocytes
Differentiation Antigens
Sulfhydryl Compounds
Oxidoreductases
T-Lymphocytes
Thymocytes
Regulatory T-Lymphocytes
tyrosinase-related protein-1
Vitiligo
T-Cell Antigen Receptor
Major Histocompatibility Complex
Autoimmunity
Disulfides
Processing
Immunotherapy
Transgenic Mice
Interleukin-2
Melanoma
Skin

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

GILT Modulates CD4 + T-Cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. / Rausch, Matthew P.; Hastings, Karen Taraszka.

In: Journal of Investigative Dermatology, Vol. 132, No. 1, 01.2012, p. 154-162.

Research output: Contribution to journalArticle

@article{bf26047ca993430f9d99b6cb2037a66d,
title = "GILT Modulates CD4 + T-Cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1",
abstract = "Gamma-IFN-inducible lysosomal thiol reductase (GILT) facilitates major histocompatibility complex class II-restricted processing through endocytic reduction of protein disulfide bonds and is necessary for efficient class II-restricted processing of melanocyte differentiation antigen, tyrosinase-related protein 1 (TRP1). Using class II-restricted, TRP1-specific T-cell receptor transgenic mice, we identify a role, to our knowledge, previously unreported, for GILT in the maintenance of tolerance to TRP1. TRP1-specific thymocytes are centrally deleted in the presence of GILT and TRP1. In contrast, CD4 + single-positive thymocytes and peripheral T cells develop in the absence of GILT or TRP1, demonstrating that GILT is required for negative selection of TRP1-specific thymocytes. Although TRP1-specific T cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do not induce vilitigo. TRP1-specific T cells that develop in the absence of GILT have diminished IL-2 and IFN-γ production. Furthermore, GILT-deficient mice have a 4-fold increase in the percentage of TRP1-specific regulatory T (Treg) cells compared with TRP1-deficient mice, and depletion of Treg cells partially restores the ability of GILT-deficient TRP1-specific CD4 + T cells to induce vitiligo. Thus, GILT has a critical role in regulating CD4 + T-cell tolerance to an endogenous skin-restricted antigen relevant to controlling autoimmunity and generating effective immunotherapy for melanoma.",
author = "Rausch, {Matthew P.} and Hastings, {Karen Taraszka}",
year = "2012",
month = "1",
doi = "10.1038/jid.2011.236",
language = "English (US)",
volume = "132",
pages = "154--162",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - GILT Modulates CD4 + T-Cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1

AU - Rausch, Matthew P.

AU - Hastings, Karen Taraszka

PY - 2012/1

Y1 - 2012/1

N2 - Gamma-IFN-inducible lysosomal thiol reductase (GILT) facilitates major histocompatibility complex class II-restricted processing through endocytic reduction of protein disulfide bonds and is necessary for efficient class II-restricted processing of melanocyte differentiation antigen, tyrosinase-related protein 1 (TRP1). Using class II-restricted, TRP1-specific T-cell receptor transgenic mice, we identify a role, to our knowledge, previously unreported, for GILT in the maintenance of tolerance to TRP1. TRP1-specific thymocytes are centrally deleted in the presence of GILT and TRP1. In contrast, CD4 + single-positive thymocytes and peripheral T cells develop in the absence of GILT or TRP1, demonstrating that GILT is required for negative selection of TRP1-specific thymocytes. Although TRP1-specific T cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do not induce vilitigo. TRP1-specific T cells that develop in the absence of GILT have diminished IL-2 and IFN-γ production. Furthermore, GILT-deficient mice have a 4-fold increase in the percentage of TRP1-specific regulatory T (Treg) cells compared with TRP1-deficient mice, and depletion of Treg cells partially restores the ability of GILT-deficient TRP1-specific CD4 + T cells to induce vitiligo. Thus, GILT has a critical role in regulating CD4 + T-cell tolerance to an endogenous skin-restricted antigen relevant to controlling autoimmunity and generating effective immunotherapy for melanoma.

AB - Gamma-IFN-inducible lysosomal thiol reductase (GILT) facilitates major histocompatibility complex class II-restricted processing through endocytic reduction of protein disulfide bonds and is necessary for efficient class II-restricted processing of melanocyte differentiation antigen, tyrosinase-related protein 1 (TRP1). Using class II-restricted, TRP1-specific T-cell receptor transgenic mice, we identify a role, to our knowledge, previously unreported, for GILT in the maintenance of tolerance to TRP1. TRP1-specific thymocytes are centrally deleted in the presence of GILT and TRP1. In contrast, CD4 + single-positive thymocytes and peripheral T cells develop in the absence of GILT or TRP1, demonstrating that GILT is required for negative selection of TRP1-specific thymocytes. Although TRP1-specific T cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do not induce vilitigo. TRP1-specific T cells that develop in the absence of GILT have diminished IL-2 and IFN-γ production. Furthermore, GILT-deficient mice have a 4-fold increase in the percentage of TRP1-specific regulatory T (Treg) cells compared with TRP1-deficient mice, and depletion of Treg cells partially restores the ability of GILT-deficient TRP1-specific CD4 + T cells to induce vitiligo. Thus, GILT has a critical role in regulating CD4 + T-cell tolerance to an endogenous skin-restricted antigen relevant to controlling autoimmunity and generating effective immunotherapy for melanoma.

UR - http://www.scopus.com/inward/record.url?scp=84856083108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856083108&partnerID=8YFLogxK

U2 - 10.1038/jid.2011.236

DO - 10.1038/jid.2011.236

M3 - Article

C2 - 21833020

AN - SCOPUS:84856083108

VL - 132

SP - 154

EP - 162

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 1

ER -